You just read:

FDA Grants Orphan Drug Designation for Tocagen's Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma

News provided by

Tocagen Inc.

Aug 25, 2015, 08:00 ET